Association between social determinants of health and time to treatment for newly diagnosed multiple myeloma

被引：0
|
作者：
Gasoyan, Hamlet
Anwer, Faiz
Kovach, Jeffrey D.
Casacchia, Nicholas J.
Wang, Ming
Rothberg, Michael B.
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
[2] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
[3] Case Western Reserve Univ, Cleveland, OH 44106 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1583
引用
收藏
页数：1
相关论文
共 50 条
  • [1] DEMOGRAPHICS, CLINICAL CHARACTERISTICS, AND TREATMENT OUTCOMES OF PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA IN THE US ACROSS SOCIAL DETERMINANTS OF HEALTH (SDOH)
    Boytsov, N.
    Multani, J.
    Zhou, Z.
    Kotowsky, N.
    Bolgioni-Smith, A.
    Huo, T.
    Paltanwale, Q.
    McNamara, S.
    Chen, C. C.
    VALUE IN HEALTH, 2024, 27 (06) : S378 - S378
  • [2] Treatment of newly diagnosed multiple myeloma
    Palumbo A.
    Magarotto V.
    Larocca A.
    Bringhen S.
    Falco P.
    Di Raimondo F.
    Baldini L.
    Boccadoro M.
    Current Hematologic Malignancy Reports, 2008, 3 (2) : 107 - 114
  • [3] Clinical treatment of newly diagnosed multiple myeloma
    Cejalvo, Maria J.
    de la Rubia, Javier
    EXPERT REVIEW OF HEMATOLOGY, 2015, 8 (05) : 595 - 611
  • [4] Relationship Between Lenalidomide Dose Modification and Time to Next Treatment in Newly Diagnosed Multiple Myeloma Patients
    Usmani, Saad Z.
    Binder, Gary
    Milentijevic, Dejan
    Hu, X. Henry
    Nagarwala, Yasir
    Corvino, Frank A.
    Arikian, Steven R.
    Surinach, Andy
    Harwin, William N.
    BLOOD, 2014, 124 (21)
  • [5] Treatment paradigms for the newly diagnosed patient with multiple myeloma
    Greipp, P
    SEMINARS IN HEMATOLOGY, 2005, 42 (04) : S16 - S21
  • [6] Continuous Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma
    Palumbo, Antonio
    Hajek, Roman
    Delforge, Michel
    Kropff, Martin
    Petrucci, Maria Teresa
    Catalano, John
    Gisslinger, Heinz
    Wiktor-Jedrzejczak, Wieslaw
    Zodelava, Mamia
    Weisel, Katja
    Cascavilla, Nicola
    Iosava, Genadi
    Cavo, Michele
    Kloczko, Janusz
    Blade, Joan
    Beksac, Meral
    Spicka, Ivan
    Plesner, Torben
    Radke, Joergen
    Langer, Christian
    Ben Yehuda, Dina
    Corso, Alessandro
    Herbein, Lindsay
    Yu, Zhinuan
    Mei, Jay
    Jacques, Christian
    Dimopoulos, Meletios A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (19): : 1759 - 1769
  • [7] Evolution of Treatment Paradigms in Newly Diagnosed Multiple Myeloma
    Elnair, Radowan A.
    Holstein, Sarah A.
    DRUGS, 2021, 81 (07) : 825 - 840
  • [8] TREATMENT OF NEWLY DIAGNOSED MULTIPLE MYELOMA: GOALS AND OPTIONS
    Tacchetti, P.
    Zamagni, E.
    Pantani, L.
    Cavo, M.
    HAEMATOLOGICA, 2017, 102 : 212 - 215
  • [9] Evolving Paradigms in the Treatment of Newly Diagnosed Multiple Myeloma
    Larocca, Alessandra
    Palumbo, Antonio
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2011, 9 (10): : 1186 - 1196
  • [10] The role of carfilzomib in treatment of newly diagnosed multiple myeloma
    Strifler, Susanne
    Knop, Stefan
    FUTURE ONCOLOGY, 2018, 14 (30) : 3123 - 3134
12345